Skip to main content
. 2017 May 26;595(13):4379–4398. doi: 10.1113/JP274066

Table 6.

Hepatic lipid concentrations in 12‐week‐old male and female offspring exposed to sucrose or HFCS‐55 during the prenatal and/or suckling periods

C‐C S‐S S‐C C‐S P‐value C‐C H‐H H‐C C‐H P‐value
12 week male n = 6 n = 5 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6
Total liver fat content (%) 8.1 ± 1.9 7.0 ± 0.6 7.2 ± 0.9 5.1 ± 0.4 0.406 8.1 ± 1.9 5.4 ± 0.7 5.7 ± 0.8 6.7 ± 0.9 *0.352
TG (mg 100 g–1) 1463 ± 128 1011 ± 19 1410 ± 224 1624 ± 128 *0.279 1463 ± 128 1313 ± 184 1897 ± 195 1502 ± 245 0.204
FFA (mg 100 g–1) 104.9 ± 4.5 106.4 ± 2.5 114.8 ± 7.0 107.1 ± 6.6 *0.601 104.9 ± 4.5 115.9 ± 6.4 124.8 ± 2.3 119.2 ± 10.2 *0.252
Phospholipid (mg 100 g–1) 2367 ± 148 3407 ± 533 2406 ± 77 2327 ± 21 , # 0.036 2367 ± 148 2421 ± 70 2649 ± 193 2571 ± 69 0.408
SFA (mg 100 g–1) 1275 ± 50 1196 ± 66 1290 ± 44 1250 ± 65 *0.723 1275 ± 50 1255 ± 33 1433 ± 46 1278 ± 85 0.146
MUFA (mg 100 g–1) 641.6 ± 63.0 683.1 ± 180.5 683.3 ± 48.9 806.1 ± 97.6 0.694 641.6 ± 63.0 762.1 ± 95.5 834.5 ± 93.5 751.1 ± 115.3 0.551
n‐3 (mg 100 g–1) 261.6 ± 8.6 244.3 ± 15.4 268.5 ± 10.2 253.6 ± 6.7 *0.420 261.6 ± 8.6 264.2 ± 5.6 289.9 ± 12.2 257.5 ± 20.1 *0.315
n‐6 (mg 100 g–1) 1362 ± 123 1269 ± 35 1288 ± 70 1143 ± 29 0.344 1362 ± 123 1299 ± 56 1598 ± 75 1443 ± 184 0.350
n‐7 (mg 100 g–1) 112.4 ± 12.0 95.9 ± 5.5 116.9 ± 7.0 106.4 ± 7.0 0.385 112.4 ± 12.0 148.8 ± 8.4 129.1 ± 4.0 143.7 ± 10.1 0.052
n‐9 (mg 100 g–1) 506.4 ± 49.7 557.3 ± 158.0 505.9 ± 69.6 676.7 ± 81.6 0.507 506.4 ± 49.7 609.6 ± 92.4 687.3 ± 90.8 600.9 ± 116.4 0.580
12 week female n = 6 n = 5 n = 6 n = 6 n = 6 n = 6 n = 6 n = 6
Total liver fat content (%) 4.4 ± 0.2 4.1 ± 0.2 9.7 ± 2.3 5.6 ± 1.0 0.032 4.4 ± 0.2 6.4 ± 1.0 6.4 ± 1.6 7.4 ± 0.6 *0.261
TG (mg 100 g–1) 1883 ± 185 1324 ± 151 1951 ± 249 1927 ± 370 *0.428 1883 ± 185 2110 ± 572 2350 ± 392 1665 ± 198 0.605
FFA (mg 100 g–1) 193.8 ± 42.4 138.0 ± 10.3 172.2 ± 11.4 189.4 ± 36.9 *0.668 193.8 ± 42.4 163.1 ± 16.2 173.2 ± 18.3 237.3 ± 60.3 *0.554
Phospholipid (mg 100 g–1) 2555 ± 93 2397 ± 69 2387 ± 65 2493 ± 42 #0.372 2555 ± 93 2502 ± 77 2497 ± 57 2502 ± 66 0.939
SFA (mg 100 g–1) 1618 ± 260 1211 ± 67 1432 ± 56 1597 ± 194 *0.458 1618 ± 260 1540 ± 137 1518 ± 99 1451 ± 272 0.951
MUFA (mg 100 g–1) 837.0 ± 195.3 511.3 ± 10.9 847.3 ± 91.4 875.3 ± 162.9 0.516 837.0 ± 195.3 694.7 ± 88.6 743.5 ± 80.4 864.0 ± 218.1 0.885
n‐3 (mg 100 g–1) 346.2 ± 52.8 268.0 ± 17.8 328.3 ± 11.4 363.8 ± 42.7 *0.427 346.2 ± 52.8 330.3 ± 22.1 334.8 ± 23.9 358.3 ± 68.1 *0.973
n‐6 (mg 100 g–1) 1471 ± 228 1175 ± 85 1157 ± 35 1349 ± 168 0.513 1471 ± 228 1365 ± 159 1479 ± 166 1291 ± 214 0.889
n‐7 (mg 100 g–1) 117.0 ± 18.1 86.4 ± 5.5 96.2 ± 6.8 107.8 ± 12.4 0.416 117.0 ± 18.1 121.0 ± 19.3 107.3 ± 9.8 127.7 ± 23.7 0.884
n‐9 (mg 100 g–1) 711.5 ± 177.0 419.6 ± 12.7 742.9 ± 89.3 756.4 ± 151.8 0.509 711.5 ± 177.0 648.8 ± 45.0 744.0 ± 126.2 726.2 ± 195.8 0.983

Data are presented as mean ± SEM. The reported P‐value indicates the effect of treatment within each sex, as determined by the one‐way ANOVA. a,bDifferent superscript letters denote mean values that were significantly different from each other (P < 0.05) within each experimental grouping. *A significant effect of offspring sex, independent of treatment, within each experimental grouping. #A significant interaction between treatment and sex, as determined by the two‐way ANOVA. While the one‐way ANOVA identified a significant effect of treatment, no significant differences were detected between treatments by the Bonferroni post hoc test. TG, triglyceride; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid; FFA, free fatty acid; n‐3, omega‐3; n‐6, omega‐6; n‐7, omega‐7; n‐9, omega‐9.